Proffitt & Goodson’s CME Group CME Stock Holding History

Proffitt & Goodson’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5	Closed	-$1.1K	–	264
2024 Q3	$1.1K	Buy	+5	New	+$1.03K	﹤0.01%	286

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Proffitt & Goodson's CME Position: Q4 2024 in Review

Proffitt & Goodson sold out of CME Group (CME) in Q4 2024, closing a stake of 5 shares — an estimated $1.1K sold.

Proffitt & Goodson first reported a position in CME in Q3 2024 and held it in 1 quarter. The position peaked at $1.1K in Q3 2024. 1,500 funds tracked by Wall St. Rank hold CME as of Q4 2024.

Proffitt & Goodson reported no remaining CME Group position as of Q4 2024 after selling out during the quarter.
Proffitt & Goodson sold 5 CME Group shares in Q4 2024, an estimated $1.1K.
Proffitt & Goodson first reported a position in CME Group in Q3 2024 and held it in 1 quarter.
Proffitt & Goodson's CME Group position peaked at $1.1K in Q3 2024.
1,500 funds tracked by Wall St. Rank held CME Group as of Q4 2024.

Based on Proffitt & Goodson's 13F filing for Q4 2024, filed 5 Feb 2025.